The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor
Alamelu G Bharadwaj1,2, Emma Kempster1, David M Waisman1,2
1Departments of Pathology, Dalhousie University, Halifax, NS B3H 1X5, Canada.
Biomolecules
|December 24, 2021
Summary
The ANXA2/S100A10 complex (AIIt) acts as a key cell surface plasminogen receptor, regulating plasmin generation crucial for cancer progression. S100A10 shows potential as an oncogenic plasminogen receptor biomarker.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Plasmin generation at the cell surface, initiated by plasminogen binding to receptors, is vital for physiological processes like fibrinolysis and wound healing.
- Cancer cells hijack cell surface plasminogen receptors to promote tumor development, progression, and metastasis.
- S100A10, in complex with annexin A2 (ANXA2) forming the AIIt heterotetramer, is a critical plasminogen receptor.
Purpose of the Study:
- To highlight the ANXA2/S100A10 (AIIt) complex as the quintessential cellular plasminogen receptor.
- To introduce and define 'oncogenic plasminogen receptor' for receptors activated during cancer progression.
- To review evidence supporting AIIt's role as an oncogenic plasminogen receptor and its potential as a cancer biomarker.
Main Methods:
- Review of existing research on cell surface plasminogen receptors, focusing on S100A10 and the AIIt complex.
- Discussion of molecular mechanisms involving AIIt in regulating plasmin formation and degradation.
- Analysis of studies linking AIIt activation to oncogenes (SRC, RAS, HIF1α, PML-RAR) and epigenetic modifications (DNA methylation) during epithelial-mesenchymal transition (EMT).
Main Results:
- AIIt is identified as a key regulator of both plasmin formation and destruction, functioning as the primary cellular plasminogen receptor.
- AIIt is established as an oncogenic plasminogen receptor, activated during EMT and by oncogenic signaling pathways.
- Animal models provide evidence for S100A10's involvement in tumor progression and oncogenesis.
Conclusions:
- The ANXA2/S100A10 (AIIt) complex is a critical regulator of plasmin generation and a significant factor in cancer progression.
- S100A10, as part of AIIt, functions as an oncogenic plasminogen receptor.
- S100A10 holds promise as a potential biomarker for cancer diagnosis and prognosis.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Anaphase Promoting Complex
3.0K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Cytoskeletal Linker Proteins - Plakins
2.5K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.5K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Intracellular Signaling Affects Focal Adhesions
2.9K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.9K


